Insulin resistance assessed by estimated glucose disposal rate and risk of atherosclerotic cardiovascular diseases incidence: the multi-ethnic study of atherosclerosis
Authors:
Open Access
- 28 September 2024
- journal article
- research article
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 23 (1) , 1-12
Abstract
To investigate the relationship between estimated glucose disposal rate (eGDR), a surrogate indicator of insulin resistance, and atherosclerotic cardiovascular diseases (ASCVD) incidence risk. This prospective cohort study utilized data from the 6026 participants from the Multi-Ethnic Study of Atherosclerosis. The eGDR (mg/kg/min) was computed as 21.158 − (0.09 × waist circumference [cm]) − (3.407 × hypertension [yes/no]) − (0.551 × HbA1c [%]). The population was categorized into four subgroups according to the quartiles (Q) of eGDR. Cox proportional hazard models were applied to assess the associations between eGDR and ASCVD incidence, and restricted cubic spine (RCS) was employed to examine the dose–response relationship. The mean age of participants was 63.6 ± 10.1 years, comprising 3163 (52.5%) women. Over a median follow-up duration of 14.1 years, 565 (9.4%) developed ASCVD, including 256 (4.2%) myocardial infarctions, 234 (3.9%) strokes, and 358 (5.9%) fatal coronary heart disease. Compared to the lowest quartile, the adjusted hazard ratios (95% confidence intervals) for incident ASCVD for Q2–Q4 were 0.87 (0.68−1.10), 0.63 (0.47−0.84), and 0.43 (0.30−0.64), respectively. Per 1 standard deviation increase in eGDR was associated with a 30% (HR: 0.70, 95% CI 0.60−0.80) risk reduction of ASCVD, with the subgroup analyses indicating that age and hypertension modified the association (P for interaction < 0.05). RCS analysis indicated a significant and linear relationship between eGDR and ASCVD incidence risk. eGDR level was negatively associated with incident ASCVD risk in a linear fashion among the general population. Our findings may contribute to preventive measures by improving ASCVD risk assessment.Keywords
Funding Information
- Capital’s Funds for Health Improvement and Research (CFH 2022-1-2062)
This publication has 49 references indexed in Scilit:
- The metabolic syndrome—a new worldwide definitionThe Lancet, 2005
- Molecular Mechanisms of Insulin Resistance That Impact Cardiovascular BiologyDiabetes, 2004
- Risk Factor Groupings Related to Insulin Resistance and Their Synergistic Effects on Subclinical AtherosclerosisDiabetes, 2002
- Subclinical Atherosclerosis and Estimated Glucose Disposal Rate as Predictors of Mortality in Type 1 DiabetesAnnals of Epidemiology, 2002
- HOMA-Estimated Insulin Resistance Is an Independent Predictor of Cardiovascular Disease in Type 2 Diabetic SubjectsDiabetes Care, 2002
- Cardiovascular Morbidity and Mortality Associated With the Metabolic SyndromeDiabetes Care, 2001
- Can clinical factors estimate insulin resistance in type 1 diabetes?Diabetes, 2000
- Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.Diabetes Care, 2000
- Prediction of Coronary Heart Disease Using Risk Factor CategoriesCirculation, 1998
- Insulin Sensitivity and AtherosclerosisCirculation, 1996